<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01202604</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-NGR-DUM-2010/1</org_study_id>
    <nct_id>NCT01202604</nct_id>
  </id_info>
  <brief_title>A Study Evaluating the Efficacy of Administered Maintenance Treatments in Bipolar Disorder I and II.</brief_title>
  <official_title>Prospective, Observational Study for the Maintenance Treatment of Patients With Bipolar Disorder I and II in Greece.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of the study is to evaluate the efficacy of administered maintenance
      treatments in bipolar disorder I and II, defined as the percentage of patients who experience
      a relapse episode during the first 9 months after a mood event (manic or depressive).
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The proportion of patients (n, %) who will experience a relapse episode (manic, hypomanic, depressive, mixed)</measure>
    <time_frame>During the first 9 months after the acute mood episode or in case of relapse occurrence.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Description of administered treatments for the management of the acute phase of bipolar disorder [mood stabilizers (n,%), antidepressants (n,%), and antipsychotics (n,%)].</measure>
    <time_frame>4 months and 9 months after the acute mood episode or in case of relapse occurrence</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Description of management of relapse episodes in patients previously receiving treatment during the maintenance phase</measure>
    <time_frame>In all visits - during the whole study period (9 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>YMRS total score, HAM-D total score</measure>
    <time_frame>At baseline and final visit (9 months after the acute mood episode)</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">294</enrollment>
  <condition>Bipolar Disorder</condition>
  <arm_group>
    <arm_group_label>Outpatients with bipolar disorder I or II (as per DSM-IV)</arm_group_label>
    <description>The percentage of patients who experience a relapse episode during the first 9 months after a mood event (manic or depressive).</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Outpatients diagnosed with bipolar disorder I or II (as per DSM-IV), who have received
        therapy with at least one atypical antipsychotic for the acute episode and whose treating
        physician has considered they have entered the maintenance phase.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects who experienced the last acute mood episode during the last 2 months and are
             in euthymic state (YMRS score ≤12 and HAM-D score ≤12) for at least two weeks

          -  Diagnosis of bipolar disorder I or II (as per DSM-IV), with or without rapid cycling

          -  Subjects who have been treated with at least one atypical antipsychotic for the
             management of an acute mood event (manic or depressive) as monotherapy or in
             combination with other medication

          -  Provision of informed consent prior to study participation

        Exclusion Criteria:

          -  Subjects fulfilling criteria for diagnosis of any other psychiatric condition (except
             from bipolar disorder I or II), as per DSM-IV Axis Ι, concomitant organic mental
             disorder or mental retardation

          -  Subjects who have received treatment with a depot

          -  Substance abuse or dependence (with the exception of nicotine dependence), as defined
             by DSM-IV criteria

          -  Inability of subjects to comply with the study protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Panagiotis Pontikis</last_name>
    <role>Study Director</role>
    <affiliation>AstraZeneca S.A. Greece</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Aigio</city>
        <state>Achaias</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ag. Paraskevi</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Athens</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Chaidari</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Drapetsona</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Elefsina</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Glyfada</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ilissia</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kifisia</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Koropi</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Maroussi</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>N. Kosmos</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Pagrati</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Petroupoli</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Piraeus</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Thiva</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Vironas</city>
        <state>Attikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ag. Nikolaos</city>
        <state>Crete</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Agrinio</city>
        <state>Etoloakarnania</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Arta</city>
        <state>Etoloakarnania</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Alexandroupolis</city>
        <state>Evros</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Lamia</city>
        <state>Fhiotidos</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Amaliada</city>
        <state>Ilias</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Karditsa</city>
        <state>Karditsas</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Katerini</city>
        <state>Katerinis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Kavala</city>
        <state>Kavalas</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Sparti</city>
        <state>Lakonias</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Edessa</city>
        <state>Pellas</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Giannitsa</city>
        <state>Pellas</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Preveza</city>
        <state>Prevezis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Thessaloniki</city>
        <state>Thessalonikis</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Trikala</city>
        <state>Trikalon</state>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Serres</city>
        <country>Greece</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Greece</country>
  </location_countries>
  <verification_date>December 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 14, 2010</study_first_submitted>
  <study_first_submitted_qc>September 14, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2010</study_first_posted>
  <last_update_submitted>December 19, 2011</last_update_submitted>
  <last_update_submitted_qc>December 19, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 20, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Bipolar disorder I and II</keyword>
  <keyword>mood event</keyword>
  <keyword>manic or depressive</keyword>
  <keyword>Greece</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Bipolar Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

